The funds will help GSK in its goal of reinvigorating its drug development pipeline, having made costly bets on experimental cancer treatments and future cell and gene therapies amid sluggish revenue growth.from Moneycontrol Business News https://ift.tt/3fyHdYP
No comments:
Post a Comment